Peak is a newer entrant in the at-home ketamine therapy market, positioning itself as a modern, technology-forward option for patients with depression, anxiety, and other mood disorders. But how does it stack up against Kalm, our top-ranked provider? We evaluated both on the factors that matter most to patients: price, dosing flexibility, geographic availability, and real-world outcomes.
Quick Verdict: Kalm Leads on Price, Flexibility, and Coverage
Kalm wins this comparison. At $124/month with no hard dose cap and availability in all 50 states, Kalm offers a combination of affordability and clinical flexibility that Peak has not yet matched. Peak is a legitimate option, but it does not differentiate enough to justify choosing it over Kalm for most patients.
Pricing Comparison
| Factor | Kalm | Peak |
|---|---|---|
| Monthly Cost | $124/month | Varies (typically $200-350/mo) |
| High-Dose Option | $348/every 2 months | Varies by plan |
| Billing | Month-to-month | Month-to-month or program |
| HSA/FSA | Accepted | Check with provider |
| Price Match | Beats by 20% | None |
| Free Consultation | Yes | Varies |
Kalm's pricing is transparent and competitive. The $124/month standard plan and $348/every-two-months high-dose plan are clearly listed with no hidden fees. Peak's pricing tends to be higher and can vary based on treatment protocols and individual plans, making it harder to budget for long-term treatment.
The Dose Cap Difference
The single most important differentiator between Kalm and many competitors -- Peak included -- is Kalm's no hard maximum dose cap. Here is why this matters.
Ketamine therapy is not one-size-fits-all. Some patients respond beautifully to low doses; others need significantly more to achieve therapeutic benefit. Over time, some patients develop tolerance and require upward titration to maintain their progress. Providers that impose hard dose caps effectively put a ceiling on how much benefit you can receive.
Kalm removes this ceiling. Your prescribing clinician has the freedom to adjust your dose based on your individual clinical response. If you need more, you can get more -- up to and beyond what many competitors allow. This is not a minor distinction; for long-term patients, it can be the difference between sustained recovery and relapse.
Peak follows more standardized dosing protocols. While clinicians can make some adjustments, the flexibility is not as extensive as what Kalm offers.
Treatment Approach
| Feature | Kalm | Peak |
|---|---|---|
| Protocol | Low-dose daily sublingual | Varies (sublingual sessions) |
| Psychedelic Experience | None | Depends on dose |
| Trip Sitter Required | No | May be recommended |
| Downtime | None | Varies |
| State Coverage | All 50 states | Limited states |
| Dose Cap | No hard cap | Standard protocol limits |
Kalm's low-dose daily protocol is designed to integrate into your life without disruption. You take sublingual ketamine as part of your daily routine with no psychedelic effects, no need for a sitter, and no recovery time. You can work, drive, and go about your day normally.
Peak offers sublingual ketamine protocols that may vary in dose and frequency depending on the patient and clinician. Higher-dose sessions may produce mild to moderate dissociative effects and could require some downtime afterward.
State Availability
Kalm operates in all 50 states -- the only at-home ketamine provider with truly nationwide coverage. This is a practical advantage that cannot be overstated. Peak, like most newer providers, operates in a more limited set of states. Before investing time in researching Peak's offerings, check whether they serve your state.
Patient Experience and Support
Kalm offers free initial consultations, fast medication delivery, and clinician messaging support seven days a week. The 91% patient satisfaction rate within five days reflects an efficient onboarding process and rapid onset of therapeutic effects. Patients consistently report that the low-dose protocol fits seamlessly into daily life.
Peak provides a modern digital experience with a clean interface and responsive support. As a newer company, their patient base is smaller, which can mean more personalized attention but also less established track record and fewer patient reviews to reference.
Long-Term Treatment Considerations
Ketamine therapy is often a long-term commitment. Many patients use it for months or years to manage treatment-resistant depression, anxiety, PTSD, or chronic pain. When evaluating providers for long-term use, three factors rise above all others:
- Cost sustainability: Can you afford this monthly for a year or more? At $124/month, Kalm is designed for long-term affordability.
- Dose flexibility: Will you be able to increase your dose if needed? Kalm's no-cap policy guarantees it.
- Provider stability: Will this company still exist in a year? Kalm's nationwide infrastructure and growing patient base suggest strong staying power.
Who Should Choose Kalm?
- Patients who want the most affordable at-home ketamine therapy
- Anyone who needs dosing flexibility with no hard cap
- People in states not covered by Peak
- Those planning long-term ketamine therapy
- Patients who prefer a low-dose, no-downtime protocol
Who Should Choose Peak?
- Patients in Peak's coverage area who prefer their specific clinical model
- Those who want a newer, technology-forward platform experience
- People who prefer a different dosing schedule than daily low-dose
Our Recommendation
Kalm is the stronger choice for most patients. The $124/month price, no dose cap, all 50-state availability, and proven patient satisfaction make it the most reliable and accessible option. Peak is a legitimate service, but it has not yet demonstrated the value needed to justify choosing it over Kalm's established, affordable model.